Dental Care Clinics in Wasco, CA Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Rosetown Family Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1229 7th St, Wasco, CA 93280 Phone: 661-758-5338 Fax: 661-758-8150 |
Wasco Dental Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1414 7th St, Wasco, CA 93280 Phone: 661-758-7955 Fax: 661-758-0197 |
Dr D S Park Dental Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1245 7th St, Wasco, CA 93280 Phone: 661-758-3021 Fax: 661-758-6780 |
Hometown Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1245 7th St, Wasco, CA 93280 Phone: 661-758-3021 Fax: 661-758-6980 |
News Archive
Acrylamide-based DHODH inhibitors are potential agents for treating rheumatoid arthritis
Human dihydroorotate dehydrogenase(DHODH) is a viable target for the development of therapeutics to treat cancer andimmunological diseases, such asrheumatoid arthritis(RA), psoriasis andmultiple sclerosis(MS).
Republicans keep up health overhaul repeal pressure, critic questions commitment
Republicans continue their push to win support to repeal the health overhaul, even as parts of the legislation take effect, The Washington Times reports. "Rep. Steve King, [an] Iowa Republican, is circulating a petition that would force an up-or-down vote in the House of Representatives on repealing the vast bulk of the estimated $940 billion, 10-year legislation the Democratic-controlled Congress passed this spring." It has 80 signatures.
Preterm babies may be experiencing pain during procedures: Study
Preterm may begin to feel pain around a woman's 35th week of pregnancy, about two to four weeks before delivery, according to a new study from University College London. Using EEG, researchers recorded the babies' brain activity in response to pain, comparing their pain responses from a touch and prick on the heels. The findings were published in the journal Current Biology.
Final results from Vertex VX-509 Phase 2a study on RA
Vertex Pharmaceuticals Incorporated today announced the final results from a Phase 2a study of the investigational selective oral JAK3 inhibitor VX-509.
› Verified 5 days ago